St. Louis, MO 的 克隆氏症 臨床試驗
19 項針對 克隆氏症 的研究正在 St. Louis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Specialists In Gastroenterology /ID# 283939, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 還有 1 項
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Washington University School of Medicine ( Site 5058), St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- SSM Health Medical Group, Bridgeton · 距離 15 英里
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Washington University /ID# 266938, St Louis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Washington University School of Medicine, St Louis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Washington University School of Medicine-Site Number: 8400075, St Louis
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
招募中3 期
- Washington University School of Medicine, St Louis
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
招募中2 期
- SSM Health DePaul Hospital- St. Louis, Bridgeton · 距離 15 英里
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- KAD Clinical Research, St Louis
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Washington University School of Medicine, St Louis
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
招募中2 期
- Washington University, St. Louis, St Louis
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
招募中2 期
- Washington University School of Medicine, St Louis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
招募中2 期
- Investigational Site Number: 8400013, St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Bridgeton · 距離 15 英里
Treatment of Moderate to Severe Refractory Crohn's Disease
招募中1/2 期
- Washington University in St. Louis, St Louis
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
招募中觀察性研究
- Washington University in St Louis School of Medicine, St Louis
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Boston, MA19 項研究
- Miami, FL19 項研究
- Cleveland, OH19 項研究
- Tyler, TX17 項研究
- Orlando, FL17 項研究
- Houston, TX17 項研究
- Atlanta, GA17 項研究
- San Antonio, TX15 項研究
- Los Angeles, CA15 項研究
- San Diego, CA15 項研究
- Colorado Springs, CO13 項研究
St. Louis 的其他研究
- 非小細胞肺癌73 項研究
- 乳癌64 項研究
- 轉移性癌症54 項研究
- 大腸直腸癌50 項研究
- 癌症（所有類型）46 項研究
- 前列腺癌46 項研究
- 肺癌39 項研究
- 卵巢癌38 項研究
- 胰臟癌33 項研究
- 子宮內膜癌29 項研究
- 頭頸部鱗狀細胞癌28 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。